Author

Xiaoqing Hu

Peking UniversityORCID 0000-0001-9824-1109Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xiaoqing Hu1 paper · University of North Carolina at Chapel Hill

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Bioinformatics· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Assay:scRNA-seq· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. LibertiD· 1 shared Ao YangiD· 1 shared Beidi Chen· 1 shared Bin MaiD· 1 shared Boyang XuiD· 1 shared Boyun Lu· 1 shared Buyao Li· 1 shared Chenlu Kang· 1 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. LibertORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cell BiologyNature CommunicationsPeer-reviewedNov 28, 2025

Mechanical confinement induces ferroptosis through mitochondrial dysfunction

Fang Zhou, Robert J. Ju, Chenlu Kang…·Congying Wu

This study shows that mechanical confinement triggers ferroptosis via mitochondrial dysfunction by inducing Drp1-dependent fragmentation and cPLA2 translocation.

18 citationstop 3%

humanexperimental assay

𝕏 PostBluesky

BioinformaticsbioRxivPreprintSep 9, 2025

JointMap identified SERPINA3+ chondrocytes as a therapeutic target for osteoarthritis

Haoda Wu, Wenqiang Yan, M J Sun…·Xiaoqing Hu

The paper identifies SERPINA3+ chondrocytes as a therapeutic target for osteoarthritis using an interspecies atlas and machine learning analysis.

DOI 10.1101/2025.09.09.675251

𝕏 PostBluesky

BioengineeringCell Reports MedicinePeer-reviewedJul 1, 2025

Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in-vivo CAR-T therapy for inflamm-aging

Zihan Zhang, Bin Ma, Buyao Li…·Lei Miao

This study develops cardiolipin-mimic lipid nanoparticles for in vivo CAR-T therapy without antibody modification, treating liver fibrosis and rheumatoid arthritis via circular uPAR CAR mRNA.

58 citationstop 1%

𝕏 PostBluesky